MDT240726P75000
- 0.02
- 0.000.00%
Medtronic Newsroom
S&P 500's Biggest Loser Has a Heart Valve Problem -- WSJ
Is Medtronic Plc's (NYSE:MDT) Stock On A Downtrend As A Result Of Its Poor Financials?
Medtronic (MDT) Is a Top-Ranked Value Stock: Should You Buy?
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
With 87% Ownership of the Shares, Medtronic Plc (NYSE:MDT) Is Heavily Dominated by Institutional Owners
Medtronic Recalls Endotracheal Tube Products
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
U.S. Patient Temperature Management (Warming, Cooling) Market Analysis Report 2024-2030 Featuring Stryker, Zoll Medical, Medtronic, Bard Medical, Cincinnati Sub-Zero Products, 3M, Pintler, ECOLAB
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Is It Time To Consider Buying Medtronic Plc (NYSE:MDT)?
RBC Capital Maintains Medtronic(MDT.US) With Hold Rating, Maintains Target Price $92
Express News | RBC Capital Reiterates Sector Perform on Medtronic, Maintains $92 Price Target
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing
Medtronic Recognized for Disability Inclusion in U.S., U.K.
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $85
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 With a Remarkable 37.2% CAGR, According to Straits Research
Medtronic Price Target Cut to $85.00/Share From $88.00 by Truist Securities
Medtronic Is Maintained at Hold by Truist Securities
Truist Securities Maintains Hold on Medtronic, Lowers Price Target to $85
Indonesia Medical Devices Industry Research Report 2024-2033 Featuring Medtronic, Becton Dickinson, Johnson & Johnson, Siemens Healthineers, Philips Healthcare, GE Healthcare, & Boston Scientific